Compare Ascendis Pharma A/S (ASND) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Pinterest Inc — how do they compare? Ascendis Pharma A/S trades at $263.79 (market cap $17.74B), while Pinterest Inc trades at $22.83 (market cap $12.61B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| ASND | PINS | |
|---|---|---|
Market Cap | $17.74B | $12.61B |
Sector | Health | Media |
52-Week High | $277.18 | $39.17 |
52-Week Low | $163.32 | $15.42 |
Enterprise Value | $18.11B | $12.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ascendis Pharma (ASND) trades at $270.45, down 1.81% on the day, with a bullish technical outlook supported by moving averages and positive analyst sentiment. The company reported Q1 2026 revenue of $241 million (converted from €197 million for YORVIPATH and €44 million for SKYTROFA, Q1 2026 earnings report May 7, 2026) and beat EPS expectations, while recent news highlights clinical progress in achondroplasia and hypoparathyroidism treatments. Valuation ratios are elevated with a P/E of 31.38 and P/S of 16.94, reflecting growth expectations.
The outlook is positive due to strong revenue growth, multiple product launches, and a 92% analyst buy rating with a $321.17 price target. Key risks include high debt levels, persistent net losses despite improving margins, and reliance on successful commercialization of new therapies. The stock's upside depends on execution of growth strategy and achieving profitability.
Pinterest (PINS) trades at $22.53, down 0.71% on the day, with a bullish technical outlook supported by moving averages. The company reported revenue growth to $4.22B in 2025, with net income of $416.86M and a net margin of 9.87%. Recent news highlights AI-driven shopping initiatives and strong user growth, while analyst sentiment remains positive with a consensus price target of $27.72.
The stock presents a growth opportunity with improving profitability and strategic AI investments, but faces risks from competitive pressure and valuation concerns. Wall Street's bullish consensus suggests upside potential, though investors should monitor execution on monetization and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
